logo_hcam

Revista Médica Científica CAMbios

Periodicidad semestral: flujo continuo.

ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)

Ver PDF (Spanish)
Ver HTML (Spanish)
Ver EPUB (Spanish)

Keywords

Hypertension Pulmonary
Neonatology
Persistent Fetal Circulation Syndrome
Infant Newborn
Infant Newborn Diseases
Intensive Care Neonatal

How to Cite

1.
Diagnosis and Management of Pulmonary hypertension Persistent in Period Neonatal in the Technical Unit of Neonatology. Cambios rev. méd. [Internet]. 2023 May 17 [cited 2025 Nov. 23];22(1):e892. Available from: https://revistahcam.iess.gob.ec/index.php/cambios/article/view/892

Abstract

Persistent Pulmonary Hypertension of the Newborn (PPHN) in a medical emergency in the neonatal stage with high morbidity and mortality in neonates.

This is characterized by a sustained elevation in pulmonary vascular resistance (PVR). Previously referred to as persistent fetal circulation which is usually the result of incomplete lung transition at birth. The cause may be idiopathic, a consequence of prenatal drug therapy management, pneumonia, sepsis, or a congenital diaphragmatic hernia with pulmonary hypoplasia. Described for the first time by Gerson et al. in 1969, this pathology occurs in 2 to 6 out of every 1 000 live newborns and it is estimated that 7 to 20% of newborns who survive PNPH develop alterations in the medium or long term such as chronic lung disease, hearing impairment, intracranial hemorrhage and neurological sequelae1. Mortality reported in the literature varies between 10 and 20% and between 10 and 50% in developing countries. The mortality rate has decreased a lot in the last decade, but much remains to be done to improve neonatal care for this condition in many areas of countries in the Latin American region2.

Ver PDF (Spanish)
Ver HTML (Spanish)
Ver EPUB (Spanish)

 

The authors who publish in this journal accept the following conditions:

1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.

2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.